(Q53924881)

English

Continuous hydralazine infusion for afterload reduction.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/7259359

Continuous hydralazine infusion for afterload reduction. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/7259359

1 reference

based on heuristic

inferred from title

author name string

M T Swartz

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/7259359

G C Kaiser

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/7259359

V L Willman

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/7259359

J E Codd

4

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/7259359

D H Tyras

5

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/7259359

H B Barner

6

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/7259359

language of work or name

0 references

publication date

1 August 1981

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/7259359

The Annals of Thoracic Surgery

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/7259359

32

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/7259359

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/7259359

188-192

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/7259359

Vasodilator therapy--a physiologic approach to the treatment of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961029-6

7 January 2021

Acute and chronic effects of oral hydralazine on left ventricular pump function and renal hemodynamics in chronic left heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961029-6

7 January 2021

Oral hydralazine therapy for chronic refractory heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961029-6

7 January 2021

Direct and reflex cardiostimulating effects of hydralazine

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961029-6

7 January 2021

Oral hydralazine therapy for primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961029-6

7 January 2021

Identifiers

10.1016/S0003-4975(10)61029-6

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/7259359

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/7259359

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53924881&oldid=1576022435"